Grupo para la caracterización molecular de las neoplasias hematológicas

Foto de Grupo para la caracterización molecular de las neoplasias hematológicas

Foto de Hôpital Saint-Antoine

Hôpital Saint-Antoine

París, Francia

Publications in collaboration with researchers from Hôpital Saint-Antoine (4)

2018

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: Analysis of the FIRST trial
Leukemia, Vol. 32, Núm. 6, pp. 1404-1413

2016

Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low‐dose dexamethasone versus high‐dose dexamethasone in refractory or relapsed and refractory multiple myeloma
Haematologica, Vol. 101, Núm. 7, pp. 872-878

2015

Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone
Haematologica, Vol. 100, Núm. 10, pp. 1327-1333
Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma
Haematologica, Vol. 100, Núm. 10, pp. 1334-1339